GlioCART GmbH
PrivateLast Round
Seed
Nov 17, 2025
Total Funding Raised
$250,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlioCART GmbH operates in Healthcare & Life Sciences and is based in Allschwil. Its latest recorded funding round was a Seed round in November 2025.
GlioCART GmbH is a biotechnology company developing a dual-action CAR-T cell therapy for glioblastoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlioCART GmbH Comparables
Compare GlioCART GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chimeric Therapeutics Limited | 76% | |
| Siren Biotechnology | 75% | |
| Century Therapeutics | 73% |
For institutional investors. Book with your work email.
GlioCART GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GlioCART GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Basel | Grant |
| Venture Kick | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$190K round led by Venture Kick
For institutional investors. Book with your work email.
GlioCART GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlioCART GmbH's valuation, stock price, and market status.
Is GlioCART GmbH a public or private company?
GlioCART GmbH is a private company.
What is the current stock price of GlioCART GmbH?
GlioCART GmbH is a private company, so its shares have no public market price. Caplight tracks GlioCART GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlioCART GmbH worth (valuation)?
Valuation information for GlioCART GmbH is not publicly available.
Can I buy GlioCART GmbH stock?
GlioCART GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlioCART GmbH's last funding round?
GlioCART GmbH's most recent funding round was Seed on November 17, 2025.
Who are the main investors in GlioCART GmbH?
Key investors in GlioCART GmbH include University of Basel, Venture Kick.
Will GlioCART GmbH IPO soon?
No public IPO plans have been announced for GlioCART GmbH.
How can I track GlioCART GmbH secondary market activity?
Caplight tracks bids, offers, and trades in GlioCART GmbH's shares on secondary markets.